Skip to main content

Ilaris 150 mg/mL injection Images

Generic Name: canakinumab

This medication has been identified as Ilaris 150 mg/mL injection. It is supplied by Novartis Pharmaceuticals Corporation.

Ilaris is used in the treatment of Cryopyrin-Associated Periodic Syndromes; Familial Mediterranean Fever; Familial Cold Autoinflammatory Syndrome; Gout, Acute; Hyperimmunoglobulin D Syndrome and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Ilaris 150 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Ilaris 150 mg/mL injection medicine


Generic Name
150 mg/mL injection
Prescription only
Drug Class
Interleukin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.